Ex-warrant common
Neither base owner economics nor the subjective weighted outcome compensates for funding risk at the dated quote; bullish outcome is possible but requires much more than the current guide. Not a short-sale recommendation.
VERY HIGH: substantial funding, dilution, qualification, customer concentration and terminal dependence.What drives the estimate
Separate product ramps and financing outcomes; current earnings are not a normalized base. FCFE makes coupon, maturity and new-share ownership visible. Simple P/E meaningless while loss-making; revenue multiple omits funding and fixed costs; no forced method blend.
Case probabilities are subjective and are not statistically calibrated. Values are not price targets.
| Case | Weight | Present value | Terminal share |
|---|---|---|---|
| Bear | 30.0% | $0.00 | — |
| Base | 50.0% | $0.21 | 73.9% |
| Bull | 20.0% | $1.63 | 68.9% |
Terminal share is a fraction of present value; the bear case is a failure recovery and has no terminal value.
Forecast and financing
scenario FCFE discounted to existing common, explicit funding and dilution. The full dated ledgers show when funding and share issuance enter the calculation. Forecasts are assumptions, not company guidance.
Bear case · forecast and financing
USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.
| Year | Revenue | Gross profit | Operating expenses | FCFE | Ending cash | Ending shares |
|---|---|---|---|---|---|---|
| 2027 | 60.00 | 17.78 | 138.00 | -157.54 | 220.40 | 225.39 |
Full dated funding and share ledger
| Date | Revenue | FCFE before principal | Debt paid | Gross equity | Fees | Ending cash | Shares | Issue price | Conditional after failure |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-30 | 1.77 | -7.10 | 0.00 | 0.00 | 0.00 | 390.91 | 225.39 | — | False |
| 2026-12-31 | 3.24 | -12.96 | 0.00 | 0.00 | 0.00 | 377.95 | 225.39 | — | False |
| 2027-01-31 | 5.10 | -12.25 | 0.00 | 0.00 | 0.00 | 365.70 | 225.39 | — | False |
| 2027-02-28 | 4.60 | -11.09 | 0.00 | 0.00 | 0.00 | 354.61 | 225.39 | — | False |
| 2027-03-31 | 5.10 | -12.30 | 0.00 | 0.00 | 0.00 | 342.31 | 225.39 | — | False |
| 2027-04-30 | 4.93 | -11.93 | 0.00 | 0.00 | 0.00 | 330.38 | 225.39 | — | False |
| 2027-05-31 | 5.10 | -12.35 | 0.00 | 0.00 | 0.00 | 318.03 | 225.39 | — | False |
| 2027-06-30 | 4.93 | -11.98 | 11.80 | 0.00 | 0.00 | 294.25 | 225.39 | — | False |
| 2027-07-31 | 5.10 | -12.38 | 0.00 | 0.00 | 0.00 | 281.87 | 225.39 | — | False |
| 2027-08-31 | 5.10 | -12.40 | 0.00 | 0.00 | 0.00 | 269.47 | 225.39 | — | False |
| 2027-09-30 | 4.93 | -12.03 | 0.00 | 0.00 | 0.00 | 257.44 | 225.39 | — | False |
| 2027-10-31 | 5.10 | -12.45 | 0.00 | 0.00 | 0.00 | 244.99 | 225.39 | — | False |
| 2027-11-30 | 4.93 | -12.08 | 0.00 | 0.00 | 0.00 | 232.91 | 225.39 | — | False |
| 2027-12-31 | 5.10 | -12.51 | 0.00 | 0.00 | 0.00 | 220.40 | 225.39 | — | False |
| 2028-01-31 | 6.18 | -11.89 | 0.00 | 0.00 | 0.00 | 208.51 | 225.39 | — | False |
| 2028-02-29 | 5.78 | -11.14 | 0.00 | 0.00 | 0.00 | 197.37 | 225.39 | — | False |
| 2028-03-31 | 6.18 | -11.94 | 0.00 | 0.00 | 0.00 | 185.43 | 225.39 | — | False |
| 2028-04-28 | 5.58 | -10.80 | 0.00 | 0.00 | 0.00 | 174.63 | 225.39 | — | False |
| 2028-04-30 | 0.40 | -0.77 | 0.00 | 0.00 | 0.00 | 173.86 | 225.39 | — | False |
| 2028-05-01 | 0.20 | -0.39 | 0.00 | 0.00 | 0.00 | 173.47 | 225.39 | — | True |
Capital and terminal bridge
{
"equity_bridge": {
"opening_cash_estimate": 398.00654945054936,
"net_debt_subtracted_again": false,
"initial_shares": 225.38901900000002,
"final_shares": 225.38901900000002,
"cumulative_equity_raise": 0,
"warrant_cash": 0,
"failure_recovery": {
"unpaid_maturity": 172.5,
"date": "2028-05-01",
"unfunded_net_gap": 39.028679836949124,
"recovery_assets": 235.34230509455773,
"remaining_debt": 404.5,
"lease_claim": 9.16,
"wind_down_cost": 25,
"common_recovery": 0,
"pp_and_e_recovery_rate": 0.3,
"working_capital_recovery_rate": 0.5
}
},
"terminal_or_finite_life": {
"growth": 0.025,
"ROIC": 0.16,
"terminal_equity_value_before_minority_bound": 0,
"terminal_pv_per_share": 0,
"terminal_fraction": null,
"terminal_FCFE": 0,
"terminal_reinvestment": 0
}
}Base case · forecast and financing
USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.
| Year | Revenue | Gross profit | Operating expenses | FCFE | Ending cash | Ending shares |
|---|---|---|---|---|---|---|
| 2027 | 75.00 | 22.02 | 140.00 | -157.86 | 220.09 | 225.39 |
| 2028 | 115.00 | 34.10 | 125.00 | -300.58 | 40.00 | 350.90 |
| 2029 | 175.00 | 54.00 | 110.00 | -95.22 | 40.00 | 450.09 |
| 2030 | 255.00 | 83.20 | 112.00 | -301.19 | 40.00 | 763.83 |
| 2031 | 350.00 | 121.60 | 120.00 | -35.20 | 40.00 | 800.49 |
| 2032 | 460.00 | 165.35 | 130.00 | -13.44 | 40.00 | 814.49 |
| 2033 | 570.00 | 209.75 | 140.00 | 12.36 | 40.00 | 814.49 |
| 2034 | 670.00 | 250.40 | 150.00 | 38.05 | 40.00 | 814.49 |
| 2035 | 750.00 | 284.20 | 158.00 | 62.80 | 40.00 | 814.49 |
| 2036 | 810.00 | 307.65 | 165.00 | 80.54 | 40.00 | 814.49 |
Full dated funding and share ledger
| Date | Revenue | FCFE before principal | Debt paid | Gross equity | Fees | Ending cash | Shares | Issue price | Conditional after failure |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-30 | 1.77 | -7.10 | 0.00 | 0.00 | 0.00 | 390.91 | 225.39 | — | False |
| 2026-12-31 | 3.24 | -12.96 | 0.00 | 0.00 | 0.00 | 377.95 | 225.39 | — | False |
| 2027-01-31 | 6.37 | -12.28 | 0.00 | 0.00 | 0.00 | 365.67 | 225.39 | — | False |
| 2027-02-28 | 5.75 | -11.11 | 0.00 | 0.00 | 0.00 | 354.56 | 225.39 | — | False |
| 2027-03-31 | 6.37 | -12.33 | 0.00 | 0.00 | 0.00 | 342.23 | 225.39 | — | False |
| 2027-04-30 | 6.16 | -11.95 | 0.00 | 0.00 | 0.00 | 330.28 | 225.39 | — | False |
| 2027-05-31 | 6.37 | -12.38 | 0.00 | 0.00 | 0.00 | 317.90 | 225.39 | — | False |
| 2027-06-30 | 6.16 | -12.00 | 11.80 | 0.00 | 0.00 | 294.09 | 225.39 | — | False |
| 2027-07-31 | 6.37 | -12.40 | 0.00 | 0.00 | 0.00 | 281.69 | 225.39 | — | False |
| 2027-08-31 | 6.37 | -12.43 | 0.00 | 0.00 | 0.00 | 269.26 | 225.39 | — | False |
| 2027-09-30 | 6.16 | -12.05 | 0.00 | 0.00 | 0.00 | 257.21 | 225.39 | — | False |
| 2027-10-31 | 6.37 | -12.48 | 0.00 | 0.00 | 0.00 | 244.73 | 225.39 | — | False |
| 2027-11-30 | 6.16 | -12.10 | 0.00 | 0.00 | 0.00 | 232.62 | 225.39 | — | False |
| 2027-12-31 | 6.37 | -12.53 | 0.00 | 0.00 | 0.00 | 220.09 | 225.39 | — | False |
| 2028-01-31 | 9.74 | -10.87 | 0.00 | 0.00 | 0.00 | 209.21 | 225.39 | — | False |
| 2028-02-29 | 9.11 | -10.19 | 0.00 | 0.00 | 0.00 | 199.02 | 225.39 | — | False |
| 2028-03-31 | 9.74 | -10.92 | 0.00 | 0.00 | 0.00 | 188.10 | 225.39 | — | False |
| 2028-04-28 | 8.80 | -9.88 | 0.00 | 0.00 | 0.00 | 178.22 | 225.39 | — | False |
| 2028-04-30 | 0.63 | -0.71 | 0.00 | 0.00 | 0.00 | 177.51 | 225.39 | — | False |
| 2028-05-01 | 0.31 | -0.35 | 172.50 | 36.82 | 1.47 | 40.00 | 262.21 | 1.00 | False |
| 2028-05-31 | 9.43 | -10.47 | 0.00 | 10.91 | 0.44 | 40.00 | 273.11 | 1.00 | False |
| 2028-06-30 | 9.43 | -10.47 | 0.00 | 10.91 | 0.44 | 40.00 | 284.02 | 1.00 | False |
| 2028-07-31 | 9.74 | -10.82 | 0.00 | 11.27 | 0.45 | 40.00 | 295.29 | 1.00 | False |
| 2028-08-31 | 9.74 | -10.82 | 0.00 | 11.27 | 0.45 | 40.00 | 306.55 | 1.00 | False |
| 2028-09-30 | 9.43 | -10.47 | 0.00 | 10.91 | 0.44 | 40.00 | 317.46 | 1.00 | False |
| 2028-10-31 | 9.74 | -10.82 | 0.00 | 11.27 | 0.45 | 40.00 | 328.73 | 1.00 | False |
| 2028-11-30 | 9.43 | -10.47 | 0.00 | 10.91 | 0.44 | 40.00 | 339.63 | 1.00 | False |
| 2028-12-31 | 9.74 | -10.82 | 0.00 | 11.27 | 0.45 | 40.00 | 350.90 | 1.00 | False |
| 2029-01-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 359.33 | 1.00 | False |
| 2029-02-28 | 13.42 | -7.30 | 0.00 | 7.61 | 0.30 | 40.00 | 366.93 | 1.00 | False |
| 2029-03-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 375.36 | 1.00 | False |
| 2029-04-30 | 14.38 | -7.83 | 0.00 | 8.15 | 0.33 | 40.00 | 383.51 | 1.00 | False |
| 2029-05-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 391.94 | 1.00 | False |
| 2029-06-30 | 14.38 | -7.83 | 0.00 | 8.15 | 0.33 | 40.00 | 400.09 | 1.00 | False |
| 2029-07-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 408.51 | 1.00 | False |
| 2029-08-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 416.94 | 1.00 | False |
| 2029-09-30 | 14.38 | -7.83 | 0.00 | 8.15 | 0.33 | 40.00 | 425.09 | 1.00 | False |
| 2029-10-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 433.51 | 1.00 | False |
| 2029-11-30 | 14.38 | -7.83 | 0.00 | 8.15 | 0.33 | 40.00 | 441.67 | 1.00 | False |
| 2029-12-31 | 14.86 | -8.09 | 0.00 | 8.42 | 0.34 | 40.00 | 450.09 | 1.00 | False |
| 2030-01-31 | 21.66 | -6.15 | 0.00 | 6.41 | 0.26 | 40.00 | 456.50 | 1.00 | False |
| 2030-02-28 | 19.56 | -5.56 | 0.00 | 5.79 | 0.23 | 40.00 | 462.28 | 1.00 | False |
| 2030-03-31 | 21.66 | -6.15 | 0.00 | 6.41 | 0.26 | 40.00 | 468.69 | 1.00 | False |
| 2030-04-30 | 20.96 | -5.95 | 0.00 | 6.20 | 0.25 | 40.00 | 474.89 | 1.00 | False |
| 2030-05-31 | 21.66 | -6.15 | 0.00 | 6.41 | 0.26 | 40.00 | 481.30 | 1.00 | False |
| 2030-06-30 | 20.96 | -5.95 | 0.00 | 6.20 | 0.25 | 40.00 | 487.50 | 1.00 | False |
| 2030-07-31 | 21.66 | -6.15 | 0.00 | 6.41 | 0.26 | 40.00 | 493.90 | 1.00 | False |
| 2030-08-31 | 21.66 | -6.15 | 0.00 | 6.41 | 0.26 | 40.00 | 500.31 | 1.00 | False |
| 2030-09-15 | 10.48 | -2.98 | 232.00 | 244.77 | 9.79 | 40.00 | 745.08 | 1.00 | False |
| 2030-09-30 | 10.48 | -2.52 | 0.00 | 2.63 | 0.11 | 40.00 | 747.71 | 1.00 | False |
| 2030-10-31 | 21.66 | -5.21 | 0.00 | 5.43 | 0.22 | 40.00 | 753.14 | 1.00 | False |
| 2030-11-30 | 20.96 | -5.05 | 0.00 | 5.26 | 0.21 | 40.00 | 758.40 | 1.00 | False |
| 2030-12-31 | 21.66 | -5.21 | 0.00 | 5.43 | 0.22 | 40.00 | 763.83 | 1.00 | False |
| 2031-12-31 | 350.00 | -35.20 | 0.00 | 36.67 | 1.47 | 40.00 | 800.49 | 1.00 | False |
| 2032-12-31 | 460.00 | -13.44 | 0.00 | 14.00 | 0.56 | 40.00 | 814.49 | 1.00 | False |
| 2033-12-31 | 570.00 | 12.36 | 0.00 | 0.00 | 0.00 | 40.00 | 814.49 | — | False |
| 2034-12-31 | 670.00 | 38.05 | 0.00 | 0.00 | 0.00 | 40.00 | 814.49 | — | False |
| 2035-12-31 | 750.00 | 62.80 | 0.00 | 0.00 | 0.00 | 40.00 | 814.49 | — | False |
| 2036-12-31 | 810.00 | 80.54 | 0.00 | 0.00 | 0.00 | 40.00 | 814.49 | — | False |
Capital and terminal bridge
{
"equity_bridge": {
"opening_cash_estimate": 398.00654945054936,
"net_debt_subtracted_again": false,
"initial_shares": 225.38901900000002,
"final_shares": 814.4923438799775,
"cumulative_equity_raise": 589.1033248799775,
"warrant_cash": 0,
"failure_recovery": null
},
"terminal_or_finite_life": {
"growth": 0.025,
"ROIC": 0.16,
"terminal_equity_value_before_minority_bound": 638.1204876077585,
"terminal_pv_per_share": 0.1529214692294191,
"terminal_fraction": 0.7385161542378379,
"terminal_FCFE": 92.52747070312499,
"terminal_reinvestment": 17.134716796874997
}
}Bull case · forecast and financing
USD millions / million shares. The 2026 annual anchor is omitted; the November 14–December 31 cash stub appears in the dated ledger. The bear 2028 annual assumption row is omitted because the case stops at the May 1 failure; the dated ledger retains period-to-failure detail.
| Year | Revenue | Gross profit | Operating expenses | FCFE | Ending cash | Ending shares |
|---|---|---|---|---|---|---|
| 2027 | 85.00 | 26.40 | 142.00 | -159.35 | 218.60 | 225.39 |
| 2028 | 170.00 | 54.50 | 150.00 | -318.35 | 83.25 | 286.39 |
| 2029 | 350.00 | 109.70 | 170.00 | -150.92 | 40.00 | 323.77 |
| 2030 | 670.00 | 215.70 | 205.00 | -359.27 | 40.00 | 448.52 |
| 2031 | 1,060.00 | 370.00 | 250.00 | -66.65 | 40.00 | 471.66 |
| 2032 | 1,500.00 | 552.00 | 300.00 | 17.35 | 40.00 | 471.66 |
| 2033 | 1,920.00 | 725.10 | 350.00 | 117.88 | 40.00 | 471.66 |
| 2034 | 2,260.00 | 863.25 | 395.00 | 211.54 | 40.00 | 471.66 |
| 2035 | 2,570.00 | 979.60 | 435.00 | 294.60 | 40.00 | 471.66 |
| 2036 | 2,800.00 | 1,066.00 | 470.00 | 370.95 | 40.00 | 471.66 |
Full dated funding and share ledger
| Date | Revenue | FCFE before principal | Debt paid | Gross equity | Fees | Ending cash | Shares | Issue price | Conditional after failure |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-30 | 1.77 | -7.10 | 0.00 | 0.00 | 0.00 | 390.91 | 225.39 | — | False |
| 2026-12-31 | 3.24 | -12.96 | 0.00 | 0.00 | 0.00 | 377.95 | 225.39 | — | False |
| 2027-01-31 | 7.22 | -12.40 | 0.00 | 0.00 | 0.00 | 365.54 | 225.39 | — | False |
| 2027-02-28 | 6.52 | -11.23 | 0.00 | 0.00 | 0.00 | 354.32 | 225.39 | — | False |
| 2027-03-31 | 7.22 | -12.45 | 0.00 | 0.00 | 0.00 | 341.87 | 225.39 | — | False |
| 2027-04-30 | 6.99 | -12.08 | 0.00 | 0.00 | 0.00 | 329.79 | 225.39 | — | False |
| 2027-05-31 | 7.22 | -12.50 | 0.00 | 0.00 | 0.00 | 317.29 | 225.39 | — | False |
| 2027-06-30 | 6.99 | -12.13 | 11.80 | 0.00 | 0.00 | 293.36 | 225.39 | — | False |
| 2027-07-31 | 7.22 | -12.53 | 0.00 | 0.00 | 0.00 | 280.83 | 225.39 | — | False |
| 2027-08-31 | 7.22 | -12.56 | 0.00 | 0.00 | 0.00 | 268.28 | 225.39 | — | False |
| 2027-09-30 | 6.99 | -12.18 | 0.00 | 0.00 | 0.00 | 256.10 | 225.39 | — | False |
| 2027-10-31 | 7.22 | -12.61 | 0.00 | 0.00 | 0.00 | 243.49 | 225.39 | — | False |
| 2027-11-30 | 6.99 | -12.23 | 0.00 | 0.00 | 0.00 | 231.26 | 225.39 | — | False |
| 2027-12-31 | 7.22 | -12.66 | 0.00 | 0.00 | 0.00 | 218.60 | 225.39 | — | False |
| 2028-01-31 | 14.40 | -12.52 | 0.00 | 0.00 | 0.00 | 206.08 | 225.39 | — | False |
| 2028-02-29 | 13.47 | -11.74 | 0.00 | 0.00 | 0.00 | 194.34 | 225.39 | — | False |
| 2028-03-31 | 14.40 | -12.57 | 0.00 | 0.00 | 0.00 | 181.77 | 225.39 | — | False |
| 2028-04-28 | 13.01 | -11.38 | 0.00 | 0.00 | 0.00 | 353.39 | 286.39 | — | False |
| 2028-04-30 | 0.93 | -0.79 | 0.00 | 0.00 | 0.00 | 352.60 | 286.39 | — | False |
| 2028-05-01 | 0.46 | -0.39 | 172.50 | 0.00 | 0.00 | 179.71 | 286.39 | — | False |
| 2028-05-31 | 13.93 | -11.77 | 0.00 | 0.00 | 0.00 | 167.93 | 286.39 | — | False |
| 2028-06-30 | 13.93 | -11.80 | 0.00 | 0.00 | 0.00 | 156.14 | 286.39 | — | False |
| 2028-07-31 | 14.40 | -12.22 | 0.00 | 0.00 | 0.00 | 143.92 | 286.39 | — | False |
| 2028-08-31 | 14.40 | -12.24 | 0.00 | 0.00 | 0.00 | 131.68 | 286.39 | — | False |
| 2028-09-30 | 13.93 | -11.87 | 0.00 | 0.00 | 0.00 | 119.81 | 286.39 | — | False |
| 2028-10-31 | 14.40 | -12.29 | 0.00 | 0.00 | 0.00 | 107.52 | 286.39 | — | False |
| 2028-11-30 | 13.93 | -11.92 | 0.00 | 0.00 | 0.00 | 95.60 | 286.39 | — | False |
| 2028-12-31 | 14.40 | -12.34 | 0.00 | 0.00 | 0.00 | 83.25 | 286.39 | — | False |
| 2029-01-31 | 29.73 | -12.74 | 0.00 | 0.00 | 0.00 | 70.51 | 286.39 | — | False |
| 2029-02-28 | 26.85 | -11.53 | 0.00 | 0.00 | 0.00 | 58.98 | 286.39 | — | False |
| 2029-03-31 | 29.73 | -12.79 | 0.00 | 0.00 | 0.00 | 46.18 | 286.39 | — | False |
| 2029-04-30 | 28.77 | -12.41 | 0.00 | 6.49 | 0.26 | 40.00 | 288.55 | 3.00 | False |
| 2029-05-31 | 29.73 | -12.83 | 0.00 | 13.37 | 0.53 | 40.00 | 293.01 | 3.00 | False |
| 2029-06-30 | 28.77 | -12.42 | 0.00 | 12.94 | 0.52 | 40.00 | 297.32 | 3.00 | False |
| 2029-07-31 | 29.73 | -12.83 | 0.00 | 13.37 | 0.53 | 40.00 | 301.78 | 3.00 | False |
| 2029-08-31 | 29.73 | -12.83 | 0.00 | 13.37 | 0.53 | 40.00 | 306.23 | 3.00 | False |
| 2029-09-30 | 28.77 | -12.42 | 0.00 | 12.94 | 0.52 | 40.00 | 310.55 | 3.00 | False |
| 2029-10-31 | 29.73 | -12.83 | 0.00 | 13.37 | 0.53 | 40.00 | 315.00 | 3.00 | False |
| 2029-11-30 | 28.77 | -12.42 | 0.00 | 12.94 | 0.52 | 40.00 | 319.32 | 3.00 | False |
| 2029-12-31 | 29.73 | -12.83 | 0.00 | 13.37 | 0.53 | 40.00 | 323.77 | 3.00 | False |
| 2030-01-31 | 56.90 | -11.01 | 0.00 | 11.47 | 0.46 | 40.00 | 327.60 | 3.00 | False |
| 2030-02-28 | 51.40 | -9.95 | 0.00 | 10.36 | 0.41 | 40.00 | 331.05 | 3.00 | False |
| 2030-03-31 | 56.90 | -11.01 | 0.00 | 11.47 | 0.46 | 40.00 | 334.88 | 3.00 | False |
| 2030-04-30 | 55.07 | -10.66 | 0.00 | 11.10 | 0.44 | 40.00 | 338.58 | 3.00 | False |
| 2030-05-31 | 56.90 | -11.01 | 0.00 | 11.47 | 0.46 | 40.00 | 342.40 | 3.00 | False |
| 2030-06-30 | 55.07 | -10.66 | 0.00 | 11.10 | 0.44 | 40.00 | 346.10 | 3.00 | False |
| 2030-07-31 | 56.90 | -11.01 | 0.00 | 11.47 | 0.46 | 40.00 | 349.93 | 3.00 | False |
| 2030-08-31 | 56.90 | -11.01 | 0.00 | 11.47 | 0.46 | 40.00 | 353.75 | 3.00 | False |
| 2030-09-15 | 27.53 | -5.33 | 232.00 | 247.22 | 9.89 | 40.00 | 436.16 | 3.00 | False |
| 2030-09-30 | 27.53 | -4.99 | 0.00 | 5.20 | 0.21 | 40.00 | 437.89 | 3.00 | False |
| 2030-10-31 | 56.90 | -10.31 | 0.00 | 10.74 | 0.43 | 40.00 | 441.47 | 3.00 | False |
| 2030-11-30 | 55.07 | -9.98 | 0.00 | 10.40 | 0.42 | 40.00 | 444.94 | 3.00 | False |
| 2030-12-31 | 56.90 | -10.31 | 0.00 | 10.74 | 0.43 | 40.00 | 448.52 | 3.00 | False |
| 2031-12-31 | 1,060.00 | -66.65 | 0.00 | 69.43 | 2.78 | 40.00 | 471.66 | 3.00 | False |
| 2032-12-31 | 1,500.00 | 17.35 | 0.00 | 0.00 | 0.00 | 40.00 | 471.66 | — | False |
| 2033-12-31 | 1,920.00 | 117.88 | 0.00 | 0.00 | 0.00 | 40.00 | 471.66 | — | False |
| 2034-12-31 | 2,260.00 | 211.54 | 0.00 | 0.00 | 0.00 | 40.00 | 471.66 | — | False |
| 2035-12-31 | 2,570.00 | 294.60 | 0.00 | 0.00 | 0.00 | 40.00 | 471.66 | — | False |
| 2036-12-31 | 2,800.00 | 370.95 | 0.00 | 0.00 | 0.00 | 40.00 | 471.66 | — | False |
Capital and terminal bridge
{
"equity_bridge": {
"opening_cash_estimate": 398.00654945054936,
"net_debt_subtracted_again": false,
"initial_shares": 225.38901900000002,
"final_shares": 471.66022404142683,
"cumulative_equity_raise": 555.8136151242803,
"warrant_cash": 183,
"failure_recovery": null
},
"terminal_or_finite_life": {
"growth": 0.025,
"ROIC": 0.18,
"terminal_equity_value_before_minority_bound": 2720.96264367816,
"terminal_pv_per_share": 1.126020005056431,
"terminal_fraction": 0.6892589115045094,
"terminal_FCFE": 394.53958333333327,
"terminal_reinvestment": 63.635416666666664
}
}What changes the answer
Operating sensitivity
2036 revenue scale (ramp gradually from fixed2027) × product gross-margin percentage points · present fair value per share
| 2036 revenue scale | Gross margin change | Value / share |
|---|---|---|
| 0.75× | -5 pp | $0.05 |
| 0.75× | +0 pp | $0.11 |
| 0.75× | +5 pp | $0.17 |
| 1.00× | -5 pp | $0.12 |
| 1.00× | +0 pp | $0.21 |
| 1.00× | +5 pp | $0.31 |
| 1.50× | -5 pp | $0.25 |
| 1.50× | +0 pp | $0.39 |
| 1.50× | +5 pp | $0.54 |
| 2.00× | -5 pp | $0.38 |
| 2.00× | +0 pp | $0.57 |
| 2.00× | +5 pp | $0.78 |
Funding and other sensitivities
Present fair value per share; one assumption changed at a time.
| Assumption | Base | Bull |
|---|---|---|
| no minority bound | $0.22 | $1.71 |
| starting trade wc zero | $0.20 | $1.62 |
| starting trade wc 20m | $0.21 | $1.65 |
| new forecast NOL 80pct offset | $0.23 | $1.71 |
| half issue price | $0.12 | $1.17 |
| double issue price | $0.32 | $2.03 |
| no warrant exercise | $0.21 | $1.62 |
| cost of equity 15pct | $0.27 | $2.15 |
| cost of equity 20pct | $0.14 | $1.13 |
| opening cash plus 20m | $0.21 | $1.66 |
| opening cash minus 20m | $0.20 | $1.61 |
What the market price implies
2036 non-phone revenue required by the model to reconcile the dated $1.60 common quote, versus $810m in the base model. Mathematical solution; not demonstrated by disclosed orders or qualified capacity. No claim of physical impossibility.
Solved driver: 2036 non-phone sales scale, with linked interim cost/capital rules. Fixed assumptions: 2027 guide-midpoint start; base product margins; 8% incremental opex / 6% incremental capex / proportional WC; base debt, funding, tax, required return; no smartphone revenue/no warrant exercise.
Independent cross-check
independent competitor operating/capital evidence, not target averaging. A competitor with higher sales and lower capex does not justify capitalizing Enovix revenue at its multiple.
Amprius Q3 revenue $39.1m, GAAP gross margin 27%; its manufacturing model and capital requirements differ. These figures test the operating assumptions and are not a valuation multiple.
Return horizon & checkpoints
Revalue remaining 2031–2036 distributions and terminal at horizon using projected shares. Not a chosen target obtained by multiplying today's estimate. With no earlier payout, present/horizon values naturally reconcile at the same discount rate. Horizon: 2030-12-31. Subjective weighted future price $0.82; total return of expected cash flows -48.6%.
Scroll the table horizontally to view all columns on narrow screens.
| Scenario | 2030 price / share | Distributions / share | Total return | Annualized IRR |
|---|---|---|---|---|
| Bear | $0.00 | $0.00 | -100.0% | Undefined: zero recovery |
| Base | $0.40 | $0.00 | -75.2% | -28.7% |
| Bull | $3.13 | $0.00 | 95.3% | 17.6% |
IRR of subjective expected cash flows: -14.9%. Not computed: failure has zero recovery and no finite IRR. IRR of expected cash flows is a different quantity from a weighted mean of case IRRs.
Terminal reinvestment and capital bridge
Scenario-derived terminal capital arithmetic; not company guidance.
| Mature-state bridge · $m unless % | Base | Bull |
|---|---|---|
| next year NOPAT | 109.66 | 458.17 |
| growth | 2.5% | 2.5% |
| ROIC | 16.0% | 18.0% |
| total growth reinvestment | 17.13 | 63.64 |
| next year DA | 45.10 | 194.75 |
| incremental trade working capital | 3.44 | 11.20 |
| incremental required cash | 1.00 | 1.00 |
| implied gross capex | 57.79 | 246.19 |
| last explicit year gross capex | 61.00 | 230.00 |
| FCFE before minority | 92.53 | 394.54 |
| FCFE after minority bound | 88.64 | 377.97 |
Gross capex = D&A + total growth reinvestment − Δtrade working capital − Δrequired operating cash. Terminal FCFE = NOPAT − total growth reinvestment.
Mature-state capital reconciliation; terminal growth slows to 2.5%. Minimum operating liquidity is productive operating capital, not separately added excess cash.
- 2027 first-half accepted deliveries/backlog collection
- Korea expansion targeted Q2 2027; measure yield and output
- Actual net cost savings/quarterly cash use
- Warrant participation before Apr28 2028 and financing before May1 note maturity
Methods, assumptions & sources
All model assumptions and conventions
- Valuation date November 13, 2026 after regular-session close; USD millions and million shares except per-share prices. Price $1.60 at 4:00 p.m. America/New_York (EST), verified by Stock Analysis historical row and Investing.com. It is ex-warrant common; Nasdaq says ex/record November 13 and no exchange-administered price adjustment. No warrant value is subtracted again and this buyer receives no separate warrant distribution.
- Operating forecast periods are calendar approximations of issuer fiscal years (differences up to several days), not quoted fiscal guidance. 2027 starts at $75m/$85m base/bull, within management FY2027 $65–85m guide; bear $60m misses it. Revenue is modeled evenly within each calendar year; actual shipments are lumpy. Q4 stub uses the $9.5m midpoint over 91 fiscal-quarter days through January 3, 2027.
- We do not pretend the company has disclosed segment revenue, ASPs, accepted-unit capacity or forecast margins. Korean, eyewear and phone revenue allocations are analyst assumptions. The base requires Korea $72m→$465m and eyewear $3m→$345m in 2027–2036; phones contribute zero. This is still rapid growth, not a flat-current-loss model. The bull requires phone requalification and $1.45bn phone sales by 2036, plus $700m Korea/$650m eyewear; this is an explicitly conditional upside, not an order book.
- Product gross margins in the forecast are economic margins before stock compensation allocated centrally to operating costs, not forecasts of reported GAAP gross margin. Base Korea matures at 35%, eyewear 42%; bull Korea 38%, eyewear 45%, phones 35%. Historical GAAP and adjusted margins remain labeled separately.
- Base economic operating expense falls $140m in 2027 to $110m in 2029, then rises to $165m by 2036. This assumes substantial additional portfolio prioritization and cost reduction if phones do not requalify. It is more than the disclosed $8.5m gross annual restructuring saving and is NOT management guidance. It gives management credit for adapting, rather than retaining phone-development costs forever without phone revenue. Bull expenses grow $142m→$470m to support the successful platform.
- Economic operating costs exclude amortization of already-granted awards, whose claim is recognized in starting shares. They include a separately assumed cost for NEW employee grants/replacement compensation: $12m, $16m, $25m in 2027–2029; thereafter 4% of revenue (base minimum $25m; bull minimum $30m), included within total operating expenses, not added again. No future grant dilution is layered on that expense. Depreciation is in operating costs/gross profit and added back once; cash capex and working capital are separately deducted.
- Beginning liquidity is an estimate, not a reported November balance: $512.159m Oct4 headline less $2.103m restricted, $81.4m approximate note-purchase cash, $15.5m October buybacks, $14.549m proxy burn (40 days × Q3 $33.1m/91) and $0.6m assumed additional accrued-interest/transaction adjustment = $398.007m. The proxy is only for the elapsed period; future burn is deducted once. Unknown actual movements are tested with ±$20m.
- FCFE is EBIT minus cash interest plus interest income minus cash taxes plus depreciation minus capex minus operating working capital minus debt principal. Cash/funding ledger begins with estimated liquidity; debt coupons and repayments are in it. Do NOT add cash or subtract net debt a second time from the resulting equity present value. $172.5m 2028 notes mature May1, $232m 2030 notes mature Sep15. Other loans approximately $11.8m are conservatively repaid June2027; short-loan interest proxy 5.2%. Operating lease costs remain in operating expense; lease debt is not separately deducted except in liquidation recovery.
- Cash settlement at face and no note-to-stock conversion is assumed in these paths; historical conversion references are far above modeled common-stock outcomes but current exact adjusted conversion rates are not asserted. Unexpected in-the-money conversion could change settlement economics and requires a new model. Cash coupons 3% and 4.75% are included. Surviving cases do not assume debt refinancing or future discounted repurchases.
- A permanent $40m operating liquidity buffer is held. It is required operating capital, not excess cash to add to equity; terminal reinvestment/ROIC includes its required growth. Cash in excess is notionally distributed after debt maturity from end2030. These are valuation cash distributions, not an announced dividend or capital-return policy. Estimated cash earns 2.5% while held.
- Funding is a conditional scenario assumption, not guaranteed execution: the base raises shares at $1.00 gross per share; bull at $3.00; 4% fees reduce usable cash. Versus $1.60 now these represent a down-round and a successful rerating, respectively. Continuous monthly draws summarize timing of required capital, not a forecast of dozens of actual offerings. Base new buyers may overpay relative to that ultimately realized case; market expectations can differ from outcomes. No perfect foresight financing is assumed. Funding unavailable is explicitly the bear failure case; issue prices and availability are leading risks.
- New financing shares = gross proceeds / assumed issue price; only net proceeds enter cash. Today's common receives future distributable cash divided by the actual future share count. This recognizes new investor ownership and never adds future proceeds as free value to existing owners. The unusually large cumulative raise is a warning, not a claim the financing market will supply it.
- Starting ownership uses Nov6 212.206365m shares, plus Oct4 10.155008m unvested RSUs, 1.942943m PRSUs and 1.084703m options, all as a deliberately conservative full-vesting/dilution bound with no option-exercise proceeds. This may overcount awards vested since Oct4 and ignores forfeitures; exact Nov13 award counts are unavailable. Options have $9.81 weighted-average strike, not a single common strike. Historical share repurchases are already in Nov6 shares and are not subtracted again. Removing the entire 13.183m award/option bound modestly increases value; it is not the driver of the call.
- Base assumes the approximately 61m new warrants expire unexercised; bull assumes full CASH exercise at $3 on Apr28 2028, conditional on a $3.53 contemporaneous market-price scenario (not a target or issuer projection), even though this realized scenario has lower conditional intrinsic value at that date. That adds $183m and 61m shares. No debt is removed on the same exercise. No-warrant exercise sensitivity is provided. The Apr28 timing also assumes no earlier acceleration: $3.30 VWAP on20 of30 trading days can trigger early expiry. A single assumed quote is not an assumed trigger history. Final warrant issuance and participation remain unknown; the 61m is the Nov13 issuer estimate, replacing older inconsistent FAQ arithmetic. Holders may instead tender eligible 2028 notes; that alternative requires debt reduction without cash and is not double-credited here.
- Bear misses the guide, assumes no new financing at the first modeled minimum-liquidity breach on May1 2028 (not a prediction of a legal insolvency date), and stops operations/model continuation. Recovery uses remaining cash, 30% of book PP&E and 50% of operating working capital, then all unpaid debt including the May1 maturity, $9.16m lease claim and $25m wind-down costs. Those are recovery assumptions, not appraisals. Senior claims exceed recovery assets, leaving zero common recovery. A zero conditional failure endpoint is not proof the business/stock has zero value today.
- Required equity return is a subjective 17%, with 15–20% sensitivity. This is FCFE, not WACC. It reflects time value/systematic uncertainty; commercial success/failure is in explicit cases, not an added generic probability haircut. Scenario weights 30% failure / 50% non-phone commercialization / 20% broad platform success are judgmental, not statistically calibrated. They give the nearer commercial path the largest weight, substantial financing-failure risk, and meaningful but smaller phone upside.
- Terminal growth 2.5% with 16% base/18% bull return on incremental operating capital. Debt-free terminal FCFE = next-year after-tax operating profit × (1−g/ROIC). Terminal reinvestment includes replacement/working capital/required operating cash; final-year D&A is not a perpetually free add-back. Terminal growth slows from the explicit final-year growth rate; margin stays at the final-year level. The terminal capex bridge is disclosed. A large terminal share means considerable model dependence.
- Taxes use a full 25% on positive pretax income and zero cash tax on losses, without assigning value to unverified legacy OR new loss attributes. This is a conservative tax convention, not a jurisdiction-specific tax forecast. A sensitivity allowing 80% offset from new forecast losses is shown; the base changes only modestly. No deferred tax asset is separately added.
- Reverse case scales the non-phone revenue path gradually from unchanged 2027 to a solved 2036 endpoint; adds 8% marginal operating cost, 6% incremental productive capex, and proportional working capital. Other margins, debt, funding price, tax and discount assumptions stay fixed. This is a single driver test with linked cost rules, not free revenue. Mathematical solution is not proof of feasible capacity or management guidance. Disclosed qualified units/ASPs are insufficient to validate the required output.
- Independent Amprius check: $39.1m Q3 sales, 27% GAAP gross margin; FY2026 guidance $145m sales, at least28% gross margin and capex below$10m; adjusted EBITDA guidance at least$2.5m includes an assumed$8m grant, which is not revenue. Its fabless partner access above2GWh is not owned dedicated output. Do not copy the margin, asset turnover, grant-supported EBITDA or market multiple into Enovix. It supports commercial demand but challenges Enovix's larger fixed-cost/capital burden. Neither company publishes enough matched ASP/yield data to claim a precise unit-cost comparison.
- The Oct4 narrowly defined trade working-capital proxy is $10.538m = AR4.277 + inventory19.849 − AP12.630 − current deferred revenue0.958. It is not current full operating working capital. Other current operating assets/liabilities are assumed to offset/remain unchanged. Forward trade WC of17% base/16% bull revenue is an analyst assumption, and starting-proxy0/$20m sensitivity is supplied.
- Routejade was95.8% owned at its2023 purchase; further minority shares were bought for$0.740m in2026, but current percentage is undisclosed. NCI book equity was$2.074m Oct4, not market value. To avoid allocating all consolidated cash to common, this model withholds a conservative4.2% of positive consolidated distributions and terminal equity for minority interests. This applies the old minority fraction to MORE than the subsidiary and may overstate the claim; it is an explicit valuation bound, not actual ownership. No-NCI-bound sensitivity raises base fromabout$0.21 to$0.22 and bull fromabout$1.63 to$1.71; the call is unchanged. No separate NCI book-value subtraction is added.
- Dated Street comparison: Stock Analysis/S&P Global Nov13 average12-month target$6.81 (12 analysts; median$5.25; range$2–15) contains differently aged estimates. Fresh Nov13 B.Riley and Craig-Hallum cut to$2 from$9/$7 and moved toHold/Neutral; Oppenheimer moved toPerform with no target displayed. These are analyst 12-month targets, NOT present fair value. We do not compare a present-value discount to a future target as if horizons matched.
Equations and claim treatment
FCFE = EBIT − cash interest + interest income − cash taxes + depreciation − capex − change in operating working capital − debt principal.
New financing shares = gross equity proceeds ÷ assumed issue price. Only net proceeds enter the cash ledger; future distributions are allocated across the then-outstanding shares. The estimated cash and debt are not added or subtracted again from FCFE present value.
Existing-award amortization excluded; new grant cost already in opex. No extra generic SBC deduction.
Evidence inputs and qualifications
| Input | Value | As of | Caveat |
|---|---|---|---|
| issued outstanding common | 212206365 shares | 2026-11-06 | November 6 not record-date final count; October buybacks are already reflected in this count. |
| quarter end cash equivalents | 63.225 USD millions | 2026-10-04 | |
| quarter end short term investments | 342.273 USD millions | 2026-10-04 | |
| quarter end long term investments | 104.558 USD millions | 2026-10-04 | |
| quarter end 2028 notes face | 172.5 USD millions | 2026-10-04 | Not confirmed November 13 outstanding balance. |
| quarter end 2030 notes face | 360 USD millions | 2026-10-04 | Predates October/November repurchases. |
| 2030 notes repurchase face | 128 USD millions | 2026-11-13 filing | Aggregate Oct-Nov repurchases. |
| 2030 notes repurchase cash | 81.4 USD millions | 2026-11-13 filing | Approximate principal purchase cash, plus accrued interest. |
| 2030 remaining face | 232 USD millions | 2026-11-13 filing | Reported after disclosed repurchases; not market value. |
| postquarter october stock repurchase cash | 15.5 USD millions | 2026-11-13 filing | October buyback is reflected in November 6 outstanding count; no repurchase share count stated here. |
| short term debt | 11.7 USD millions | 2026-10-04 | Includes $0.2m current portion of long-term loans; approximate. |
| total long term loans | 0.3 USD millions | 2026-10-04 | Includes $0.2m current portion already in short-term debt; do not add both gross. |
| operating lease liabilities present value | 9.16 USD millions | 2026-10-04 | Keep valuation cash-flow and debt treatment consistent. |
| 2028 notes fair value | 154.5 USD millions | 2026-10-04 | Historical issuer estimate, not current quote. |
| 2030 notes fair value | 190.2 USD millions | 2026-10-04 | Before subsequent repurchases; not current quote. |
| expected 2026 warrants | 61.0 million warrants | 2026-11-13 filing | Issuer estimate; final distribution unknown. Older Oct 28 FAQ estimates 65.6m. |
| stock options exercisable | 1084703 options | 2026-10-04 | Weighted average strike $9.81; distribution of strike prices varies. |
| restricted stock units unvested | 10155008 RSUs | 2026-10-04 | |
| performance stock units unvested | 1942943 PRSUs | 2026-10-04 | Subject to performance and forfeiture. |
| unrecognized equity compensation | 70.8 USD millions | 2026-10-04 | Expected weighted average recognition 2.9 years; includes already-granted awards; avoid double counting. |
| private placement warrants | 0 warrants | 2026-10-04 | 5.5m expired unexercised July 14; do not confuse with 2026 dividend warrants. |
Source links
- 10-Q cover and risk factors
- Amprius Q3 2026 results
- nasdaq warrant.html
- envx faq.html
- ampx q3 10q.pdf
- ampx q3 call.pdf
- envx history.html
Quote is a dated historical close, not a live quote. Its source reference and distribution-basis documentation are retained with the model.